Inducing common mutations observed in fibroids in CRIP1+/PECAM1- myometrium cells, such as MED12 (exon 2, 131 G > A, G44D) or overexpression of HMGA2, could provide insight into fibroid etiology and models to evaluate alternative therapeutics. This evidence concerns the gene MED12 and leiomyoma.